Published in Am J Pathol on June 01, 1990
Large induction of keratinocyte growth factor expression in the dermis during wound healing. Proc Natl Acad Sci U S A (1992) 2.89
Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. Am J Pathol (2001) 2.33
Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. Am J Pathol (2007) 2.27
Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products. J Clin Invest (1993) 1.99
Wound repair and regeneration: mechanisms, signaling, and translation. Sci Transl Med (2014) 1.87
Targeted expression of a dominant-negative FGF receptor mutant in the epidermis of transgenic mice reveals a role of FGF in keratinocyte organization and differentiation. EMBO J (1993) 1.78
Platelet-derived growth factor (BB homodimer), transforming growth factor-beta 1, and basic fibroblast growth factor in dermal wound healing. Neovessel and matrix formation and cessation of repair. Am J Pathol (1992) 1.72
Platelet-derived growth factor-BB and transforming growth factor beta 1 selectively modulate glycosaminoglycans, collagen, and myofibroblasts in excisional wounds. Am J Pathol (1991) 1.69
Duodenal ulcer. Discovery of a new mechanism and development of angiogenic therapy that accelerates healing. Ann Surg (1991) 1.61
Resistance and escape from antiangiogenesis therapy: clinical implications and future strategies. J Clin Oncol (2012) 1.61
12-Hydroxyheptadecatrienoic acid promotes epidermal wound healing by accelerating keratinocyte migration via the BLT2 receptor. J Exp Med (2014) 1.54
Nicotine accelerates angiogenesis and wound healing in genetically diabetic mice. Am J Pathol (2002) 1.54
Delayed wound healing in diabetic (db/db) mice with Pseudomonas aeruginosa biofilm challenge: a model for the study of chronic wounds. Wound Repair Regen (2010) 1.44
Detection of platelet-derived growth factor (PDGF)-AA in actively healing human wounds treated with recombinant PDGF-BB and absence of PDGF in chronic nonhealing wounds. J Clin Invest (1995) 1.25
Human keratinocyte growth factor effects in a porcine model of epidermal wound healing. J Exp Med (1993) 1.24
Blocking interleukin-1β induces a healing-associated wound macrophage phenotype and improves healing in type 2 diabetes. Diabetes (2013) 1.22
The PHSRN sequence induces extracellular matrix invasion and accelerates wound healing in obese diabetic mice. J Clin Invest (2000) 1.17
CXCR4 antagonist AMD3100 accelerates impaired wound healing in diabetic mice. J Invest Dermatol (2011) 1.16
Wound healing in mice with high-fat diet- or ob gene-induced diabetes-obesity syndromes: a comparative study. Exp Diabetes Res (2011) 1.15
Sustained inflammasome activity in macrophages impairs wound healing in type 2 diabetic humans and mice. Diabetes (2013) 1.14
Expression of the oxygen-regulated protein ORP150 accelerates wound healing by modulating intracellular VEGF transport. J Clin Invest (2001) 1.13
A fragment of secreted Hsp90α carries properties that enable it to accelerate effectively both acute and diabetic wound healing in mice. J Clin Invest (2011) 1.13
Normal morphogenesis of epithelial tissues and progression of epithelial tumors. Wiley Interdiscip Rev Syst Biol Med (2011) 1.10
Inflammation in nonhealing diabetic wounds: the space-time continuum does matter. Am J Pathol (2001) 1.10
HoxD3 accelerates wound healing in diabetic mice. Am J Pathol (2003) 1.09
The prevention of incisional hernia formation using a delayed-release polymer of basic fibroblast growth factor. Ann Surg (2004) 1.09
Mesenchymal cell activation is the rate-limiting step of granulation tissue induction. Am J Pathol (1996) 1.06
Beta-glucans in the treatment of diabetes and associated cardiovascular risks. Vasc Health Risk Manag (2008) 1.06
Human keratinocytes are a major source of cutaneous platelet-derived growth factor. J Clin Invest (1993) 1.06
The Nf1 tumor suppressor regulates mouse skin wound healing, fibroblast proliferation, and collagen deposited by fibroblasts. J Invest Dermatol (1999) 1.06
Angiogenesis in wounds treated by microdeformational wound therapy. Ann Surg (2011) 1.05
Induction of specific microRNAs inhibits cutaneous wound healing. J Biol Chem (2012) 1.04
Estrogen stimulates microglia and brain recovery from hypoxia-ischemia in normoglycemic but not diabetic female mice. J Clin Invest (2004) 1.04
Adult zebrafish as a model system for cutaneous wound-healing research. J Invest Dermatol (2013) 1.04
Similarities and differences between induced organ regeneration in adults and early foetal regeneration. J R Soc Interface (2005) 1.01
Differential expression and localization of insulin-like growth factors I and II in cutaneous wounds of diabetic and nondiabetic mice. Am J Pathol (1997) 0.99
The effects of ageing on wound healing: immunolocalisation of growth factors and their receptors in a murine incisional model. J Anat (1997) 0.99
Pro-inflammatory chemokine CCL2 (MCP-1) promotes healing in diabetic wounds by restoring the macrophage response. PLoS One (2014) 0.97
PDGF induced microRNA alterations in cancer cells. Nucleic Acids Res (2011) 0.97
Multiparametric and semiquantitative scoring systems for the evaluation of mouse model histopathology--a systematic review. BMC Vet Res (2013) 0.97
A review of becaplermin gel in the treatment of diabetic neuropathic foot ulcers. Biologics (2008) 0.96
Tissue repair processes in healing chronic pressure ulcers treated with recombinant platelet-derived growth factor BB. Am J Pathol (1994) 0.93
Sequential cytokine therapy for pressure ulcers: clinical and mechanistic response. Ann Surg (2000) 0.93
Wound administration of M2-polarized macrophages does not improve murine cutaneous healing responses. PLoS One (2014) 0.93
In vitro Therapeutic Effects of Low Level Laser at mRNA Level on the Release of Skin Growth Factors from Fibroblasts in Diabetic Mice. Avicenna J Med Biotechnol (2014) 0.92
Time course study of delayed wound healing in a biofilm-challenged diabetic mouse model. Wound Repair Regen (2012) 0.91
Pistacia atlantica Resin Has a Dose-Dependent Effect on Angiogenesis and Skin Burn Wound Healing in Rat. Evid Based Complement Alternat Med (2013) 0.91
Diabetes induces stable intrinsic changes to myeloid cells that contribute to chronic inflammation during wound healing in mice. Dis Model Mech (2013) 0.90
Dual growth factor releasing multi-functional nanofibers for wound healing. Acta Biomater (2013) 0.90
Expression of platelet-derived growth factor receptors in normal and diseased human kidney. An immunohistochemistry and in situ hybridization study. J Clin Invest (1994) 0.90
Keratinocyte growth factor ameliorates dextran sodium sulfate colitis in mice. Dig Dis Sci (1999) 0.90
Implant healing in experimental animal models of diabetes. J Diabetes Sci Technol (2011) 0.90
Skin wound healing in diabetic β6 integrin-deficient mice. APMIS (2010) 0.89
The Phytochemical Shikonin Stimulates Epithelial-Mesenchymal Transition (EMT) in Skin Wound Healing. Evid Based Complement Alternat Med (2013) 0.89
Inflammatory cytokine levels in chronic venous insufficiency ulcer tissue before and after compression therapy. J Vasc Surg (2009) 0.89
Anti-vascular therapies in ovarian cancer: moving beyond anti-VEGF approaches. Cancer Metastasis Rev (2015) 0.89
Diabetes-induced alterations in the extracellular matrix and their impact on myocardial function. Microsc Microanal (2012) 0.88
Expression of growth factor and receptor mRNAs in skin epithelial cells following acute cutaneous injury. Am J Pathol (1993) 0.87
Generating and reversing chronic wounds in diabetic mice by manipulating wound redox parameters. J Diabetes Res (2014) 0.86
Platelet-derived growth factor inhibits bone regeneration induced by osteogenin, a bone morphogenetic protein, in rat craniotomy defects. J Clin Invest (1993) 0.85
Prevention of NKT cell activation accelerates cutaneous wound closure and alters local inflammatory signals. J Surg Res (2010) 0.85
A novel autologous cell-based therapy to promote diabetic wound healing. Ann Surg (2012) 0.85
Low-intensity vibration improves angiogenesis and wound healing in diabetic mice. PLoS One (2014) 0.85
The use of native chemical functional groups presented by wound beds for the covalent attachment of polymeric microcarriers of bioactive factors. Biomaterials (2012) 0.85
The use of growth factors and other humoral agents to accelerate and enhance burn wound healing. Eplasty (2011) 0.85
The effect of oral sodium taurocholate on endotoxemia and intestinal anastomotic wound healing in rats with obstructive jaundice. Surg Today (1997) 0.85
Topical substance P increases inflammatory cell density in genetically diabetic murine wounds. Wound Repair Regen (2008) 0.84
Topical application of laminin-332 to diabetic mouse wounds. J Dermatol Sci (2007) 0.84
Clinical Impact Upon Wound Healing and Inflammation in Moist, Wet, and Dry Environments. Adv Wound Care (New Rochelle) (2013) 0.84
Biocompatibility and cutaneous reactivity of cellulosic polysaccharide film in induced skin wounds in rats. J Mater Sci Mater Med (2015) 0.83
Macrophage PPARγ and impaired wound healing in type 2 diabetes. J Pathol (2015) 0.82
Fibronectin matrix mimetics promote full-thickness wound repair in diabetic mice. Tissue Eng Part A (2013) 0.82
Enzyme-Responsive Delivery of Multiple Proteins with Spatiotemporal Control. Adv Mater (2015) 0.82
Secretion of SDF-1alpha by bone marrow-derived stromal cells enhances skin wound healing of C57BL/6 mice exposed to ionizing radiation. J Cell Mol Med (2009) 0.81
Platelet-derived growth factor B-chain of hematopoietic origin is not necessary for granulation tissue formation and its absence enhances vascularization. Am J Pathol (2001) 0.81
Leptin promotes wound healing in the oral mucosa. PLoS One (2014) 0.80
The noninvasive, quantitative, in vivo assessment of adenoviral-mediated gene delivery in skin wound biomaterials. Biomaterials (2009) 0.80
No Association between Glycemia and Wound Healing in an Experimental db/db Mouse Model. ISRN Endocrinol (2013) 0.79
PDGF-BB does not accelerate healing in diabetic mice with splinted skin wounds. PLoS One (2014) 0.78
Stretch-induced human myometrial cytokines enhance immune cell recruitment via endothelial activation. Cell Mol Immunol (2014) 0.78
This paper is the winner of an SFB Award in the Hospital Intern, Residency category: Peptide biomaterials raising adaptive immune responses in wound healing contexts. J Biomed Mater Res A (2016) 0.78
alpha-Lipoic acid modulates extracellular matrix and angiogenesis gene expression in non-healing wounds treated with hyperbaric oxygen therapy. Mol Med (2008) 0.78
Combination therapy accelerates diabetic wound closure. PLoS One (2014) 0.78
A concomitant review of the effects of diabetes mellitus and hypothyroidism in wound healing. World J Gastroenterol (2006) 0.78
Cutaneous and inflammatory response to long-term percutaneous implants of sphere-templated porous/solid poly(HEMA) and silicone in mice. J Biomed Mater Res A (2012) 0.77
Enhanced regenerative healing efficacy of a highly skin-permeable growth factor nanocomplex in a full-thickness excisional mouse wound model. Int J Nanomedicine (2014) 0.76
Transgenic overexpression of keratinocyte-specific VEGF and Ang1 in combination promotes wound healing under nondiabetic but not diabetic conditions. Int J Clin Exp Pathol (2012) 0.76
Non-adenine based purines accelerate wound healing. Purinergic Signal (2006) 0.76
Thrombomodulin promotes diabetic wound healing by regulating toll-like receptor 4 expression. J Invest Dermatol (2015) 0.76
Evaluation of the potentials of autologous blood injection for healing in diabetic foot ulcers. J Am Coll Clin Wound Spec (2013) 0.75
Continuous electrical current and zinc sulphate administered by transdermal iontophoresis improves skin healing in diabetic rats induced by alloxan: morphological and ultrastructural analysis. J Diabetes Res (2014) 0.75
Topical Fibronectin Improves Wound Healing of Irradiated Skin. Sci Rep (2017) 0.75
Effect of Hominis Placenta on cutaneous wound healing in normal and diabetic mice. Nutr Res Pract (2014) 0.75
Synergistic antibacterial effect of co-administering adipose-derived mesenchymal stromal cells and Ophiophagus hannah L-amino acid oxidase in a mouse model of methicillin-resistant Staphylococcus aureus-infected wounds. Stem Cell Res Ther (2017) 0.75
Is there a field of wound pharmacology? Ann Surg (1992) 0.75
Stellera chamaejasme and its constituents induce cutaneous wound healing and anti-inflammatory activities. Sci Rep (2017) 0.75
Klotho mice: a novel wound model of aged skin. Plast Reconstr Surg Glob Open (2014) 0.75
IL-22R Ligands IL-20, IL-22, and IL-24 Promote Wound Healing in Diabetic db/db Mice. PLoS One (2017) 0.75
Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A (1986) 12.14
Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem (1986) 10.00
Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci U S A (1987) 6.43
Type beta transforming growth factor: a bifunctional regulator of cellular growth. Proc Natl Acad Sci U S A (1985) 5.93
Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia (1978) 5.21
Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J (1987) 4.56
Platelet-derived growth factor in chemotactic for fibroblasts. J Cell Biol (1982) 4.08
Accelerated healing of incisional wounds in rats induced by transforming growth factor-beta. Science (1987) 4.03
Chemotaxis of monocytes and neutrophils to platelet-derived growth factor. J Clin Invest (1982) 3.77
Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor. Science (1986) 3.52
Enhancement of wound healing by topical treatment with epidermal growth factor. N Engl J Med (1989) 3.39
Platelet-derived growth factor. II. Specific binding to cultured cells. J Biol Chem (1982) 3.20
Drugs producing diabetes through damage of the insulin secreting cells. Pharmacol Rev (1970) 3.10
Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. Science (1989) 2.98
Factor contributing to leakage of colonic anastomoses. Ann Surg (1973) 2.54
Isolation and partial molecular characterization of pituitary fibroblast growth factor. Proc Natl Acad Sci U S A (1984) 2.46
Epithelial wound healing enhanced by transforming growth factor-alpha and vaccinia growth factor. Science (1987) 2.24
Role of platelet-derived growth factor in wound healing: synergistic effects with other growth factors. Proc Natl Acad Sci U S A (1987) 2.17
Diabetes-obesity syndromes in mice. Diabetes (1982) 2.01
The reversal of an Adriamycin induced healing impairment with chemoattractants and growth factors. Ann Surg (1986) 1.94
Purification and characterization of heparin-binding endothelial cell growth factors. J Biol Chem (1986) 1.89
Stimulation of granulation tissue formation by platelet-derived growth factor in normal and diabetic rats. J Clin Invest (1985) 1.79
Molecular and biological characterization of fibroblast growth factor, an angiogenic factor which also controls the proliferation and differentiation of mesoderm and neuroectoderm derived cells. Cell Differ (1986) 1.75
Transforming growth factor beta reverses the glucocorticoid-induced wound-healing deficit in rats: possible regulation in macrophages by platelet-derived growth factor. Proc Natl Acad Sci U S A (1989) 1.73
Enhancement of epidermal regeneration by biosynthetic epidermal growth factor. J Exp Med (1986) 1.72
Effects of growth factors in vivo. I. Cell ingrowth into porous subcutaneous chambers. Am J Pathol (1987) 1.67
Stimulation of in vitro human skin collagenase expression by platelet-derived growth factor. Proc Natl Acad Sci U S A (1985) 1.65
In vivo incisional wound healing augmented by platelet-derived growth factor and recombinant c-sis gene homodimeric proteins. J Exp Med (1988) 1.64
Role of platelets and fibrin in the healing sequence: an in vivo study of angiogenesis and collagen synthesis. Ann Surg (1982) 1.62
Classification and treatment of chronic nonhealing wounds. Successful treatment with autologous platelet-derived wound healing factors (PDWHF). Ann Surg (1986) 1.61
Human endothelial cells are chemotactic to endothelial cell growth factor and heparin. J Cell Biol (1985) 1.56
Tumor necrosis factor-mediated release of platelet-derived growth factor from cultured endothelial cells. J Exp Med (1987) 1.50
Mechanical factors in abdominal wound closure: the prevention of fascial dehiscence. Surgery (1985) 1.46
Induction of collagenase secretion in human fibroblast cultures by growth promoting factors. J Biol Chem (1985) 1.42
Accelerated wound repair, cell proliferation, and collagen accumulation are produced by a cartilage-derived growth factor. J Cell Biol (1985) 1.41
Studies of wound healing in experimental diabetes mellitus. J Surg Res (1977) 1.36
Purification of human platelet-derived growth factor. Methods Enzymol (1985) 1.36
Recombinant basic fibroblast growth factor accelerates wound healing. J Surg Res (1988) 1.29
Mitogenic effect of fibroblast growth factor on early passage cultures of human and murine fibroblasts. J Cell Biol (1975) 1.20
Wound healing and the diabetic patient. Surg Gynecol Obstet (1979) 1.17
Biosynthesis and regulation of type V collagen in diploid human fibroblasts. J Biol Chem (1983) 1.08
The B chain of PDGF alone is sufficient for mitogenesis. EMBO J (1985) 1.07
Animal models of diabetes. Am J Med (1981) 1.07
Wound collagen accumulation in obese hyperglycemic mice. Diabetes (1986) 1.03
Stimulation of wound healing, using brain extract with fibroblast growth factor (FGF) activity. I. Quantitative and biochemical studies into formation of granulation tissue. Exp Pathol (1982) 1.02
Effect of growth factors with dexamethasone on healing of rabbit corneal stromal incisions. Exp Eye Res (1985) 1.00
Growth factors and wound healing in the hamster. J Dermatol Surg Oncol (1985) 0.97
Anti-islet immunity and thymic dysfunction in the mutant diabetic C57BL/KsJ db/db mouse. Diabetes (1983) 0.96
Impaired wound healing in streptozotocin diabetes. Prevention by supplemental vitamin A. Ann Surg (1981) 0.95
Brain-derived growth factor is a chemoattractant for fibroblasts and astroglial cells. Biochem Biophys Res Commun (1986) 0.93
Eye-derived growth factor isolated from bovine retina and used for epidermal wound healing in vivo. J Invest Dermatol (1986) 0.90
Healing of incisional wounds in stomach and duodenum: the influence of experimental diabetes. J Surg Res (1981) 0.89
The effect of platelet-derived growth factor on cell division and glycosaminoglycan synthesis by human skin and scar fibroblasts. J Invest Dermatol (1987) 0.85
Effects of experimental diabetes, uremia, and malnutrition on wound healing. Diabetes (1987) 0.85
Operative risks in patients with colorectal cancer. Am Surg (1985) 0.85
Deficient collagen formation by obese mice in a standard wound model. Am J Surg (1979) 0.83
The pathogenesis of atherosclerosis--an update. N Engl J Med (1986) 14.59
The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibers. J Cell Biol (1971) 10.72
A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci U S A (1974) 9.94
ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb (1994) 8.54
The biology of platelet-derived growth factor. Cell (1986) 7.17
Expression and secretion of type beta transforming growth factor by activated human macrophages. Proc Natl Acad Sci U S A (1987) 6.76
The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. Am J Pathol (1975) 6.42
Atherosclerosis and the arterial smooth muscle cell: Proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis. Science (1973) 6.38
The pathogenesis of atherosclerosis (second of two parts). N Engl J Med (1976) 5.48
Skeletal muscle mass and distribution in 468 men and women aged 18-88 yr. J Appl Physiol (1985) (2000) 5.24
The pathogenesis of atherosclerosis (first of two parts). N Engl J Med (1976) 5.22
The smooth muscle cell in culture. Physiol Rev (1979) 5.03
Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol (1985) (1998) 5.01
A significant part of macrophage-derived growth factor consists of at least two forms of PDGF. Cell (1985) 4.81
The platelet-derived growth factor. Cell (1978) 4.77
The elastic fiber. I. The separation and partial characterization of its macromolecular components. J Cell Biol (1969) 4.51
Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am J Pathol (1986) 4.51
Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation. Arteriosclerosis (1984) 4.40
Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science (1991) 4.27
A macrophage-dependent factor that stimulates the proliferation of fibroblasts in vitro. Am J Pathol (1976) 3.86
The fibroblast and wound repair. Biol Rev Camb Philos Soc (1968) 3.78
The fine structure of elastic fibers. J Cell Biol (1966) 3.68
Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arterioscler Thromb Vasc Biol (1998) 3.66
Two classes of PDGF receptor recognize different isoforms of PDGF. Science (1988) 3.59
Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content. J Appl Physiol (1985) (2000) 3.54
Platelet factors stimulate fibroblasts and smooth muscle cells quiescent in plasma serum to proliferate. J Cell Biol (1976) 3.48
Platelet-derived growth factor. I. High yield purification and evidence for multiple forms. J Biol Chem (1982) 3.35
Two different subunits associate to create isoform-specific platelet-derived growth factor receptors. J Biol Chem (1989) 3.33
Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol (1985) (2000) 3.31
Platelet-derived growth factor. II. Specific binding to cultured cells. J Biol Chem (1982) 3.20
Wound healing and collagen formation. V. Quantitative electron microscope radioautographic observations of proline-H3 utilization by fibroblasts. J Cell Biol (1965) 3.18
Experimental arteriosclerosis. I. Fibrous plaque formation in primates, an electron microscope study. J Exp Med (1972) 3.17
Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. J Clin Invest (1976) 3.04
The HL-60 transforming sequence: a ras oncogene coexisting with altered myc genes in hematopoietic tumors. Cell (1983) 3.00
Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. Science (1989) 2.98
Similar effects of platelet-derived growth factor and epidermal growth factor on the phosphorylation of tyrosine in cellular proteins. Cell (1982) 2.92
HHF35, a muscle-actin-specific monoclonal antibody. I. Immunocytochemical and biochemical characterization. Am J Pathol (1987) 2.91
Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation award lecture. Cancer Res (1988) 2.90
TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell (1990) 2.82
Coordinate control of 3T3 cell proliferation by platelet-derived growth factor and plasma components. Proc Natl Acad Sci U S A (1978) 2.80
Early changes in phosphatidylinositol and arachidonic acid metabolism in quiescent swiss 3T3 cells stimulated to divide by platelet-derived growth factor. J Biol Chem (1981) 2.77
Three different human tumor cell lines contain different oncogenes. Cell (1981) 2.77
The smooth muscle cell. I. In vivo synthesis of connective tissue proteins. J Cell Biol (1971) 2.74
Total-body skeletal muscle mass: development and cross-validation of anthropometric prediction models. Am J Clin Nutr (2000) 2.71
Thyroid dysfunction in a prospectively followed series of patients with progressive systemic sclerosis. J Endocrinol Invest (1990) 2.70
Development and testing of nursing home quality indicators. Health Care Financ Rev (1995) 2.68
The development of the rat flexor digital tendon, a fine structure study. J Ultrastruct Res (1967) 2.61
Production of platelet-derived growth factor-like molecules and reduced expression of platelet-derived growth factor receptors accompany transformation by a wide spectrum of agents. Proc Natl Acad Sci U S A (1984) 2.58
Homocystinemia. Vascular injury and arterial thrombosis. N Engl J Med (1974) 2.55
The adverse effect of iron repletion on the course of certain infections. Br Med J (1978) 2.55
Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors. Cell (1996) 2.55
Hyperlipidemia and atherosclerosis. Science (1976) 2.55
Glucose content of tracheal aspirates: implications for the detection of tube feeding aspiration. Crit Care Med (1994) 2.42
Human wound repair. I. Epidermal regeneration. J Cell Biol (1968) 2.39
Visualization of fibrous cap thickness and rupture in human atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging. Circulation (2000) 2.38
Phenotype-dependent response of cultured aortic smooth muscle to serum mitogens. J Cell Biol (1981) 2.33
Protein kinase A antagonizes platelet-derived growth factor-induced signaling by mitogen-activated protein kinase in human arterial smooth muscle cells. Proc Natl Acad Sci U S A (1993) 2.31
Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade. Mol Cell (1998) 2.29
Human atherosclerosis. I. Cell constitution and characteristics of advanced lesions of the superficial femoral artery. Am J Pathol (1984) 2.29
Immunocytochemical analysis of cellular components in atherosclerotic lesions. Use of monoclonal antibodies with the Watanabe and fat-fed rabbit. Arteriosclerosis (1986) 2.27
Serum testosterone levels in healthy young black and white men. J Natl Cancer Inst (1986) 2.27
The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro. J Clin Invest (1995) 2.23
Starvation suppression and refeeding activation of infection. An ecological necessity? Lancet (1977) 2.21
Production of platelet-derived growth factor-like molecules by cultured arterial smooth muscle cells accompanies proliferation after arterial injury. Proc Natl Acad Sci U S A (1986) 2.20
Mediation of pinocytosis in cultured arterial smooth muscle and endothelial cells by platelet-derived growth factor. J Cell Biol (1978) 2.16
Induction of transforming growth factor-alpha in activated human alveolar macrophages. Cell (1988) 2.13
Human wound repair. II. Inflammatory cells, epithelial-mesenchymal interrelations, and fibrogenesis. J Cell Biol (1968) 2.11
Response to injury and atherogenesis. Am J Pathol (1977) 2.09
Preclinical validation of a microarray method for full molecular karyotyping of blastomeres in a 24-h protocol. Hum Reprod (2010) 2.07
Human monocyte-derived growth factor(s) for mesenchymal cells: activation of secretion by endotoxin and concanavalin A. Cell (1981) 2.06
Cloning and expression of a cDNA coding for the human platelet-derived growth factor receptor: evidence for more than one receptor class. Proc Natl Acad Sci U S A (1988) 2.06
Biochemical studies of two patients with the gray platelet syndrome. Selective deficiency of platelet alpha granules. J Clin Invest (1980) 2.01
Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J Exp Med (1992) 1.98
Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation. J Clin Invest (1994) 1.97
The neutrophilic leukocyte in wound repair a study with antineutrophil serum. J Clin Invest (1972) 1.96
The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors. Proc Natl Acad Sci U S A (1992) 1.94
Effects of antimicrotubular agents on the secretion of collagen. A biochemical and morphological study. J Cell Biol (1974) 1.93
An endothelial cell-derived growth factor. J Cell Biol (1980) 1.93
Economic status and survival of cancer patients. Cancer (1977) 1.93
Proteoglycans in primate arteries. I. Ultrastructural localization and distribution in the intima. J Cell Biol (1975) 1.93
George Lyman Duff Memorial Lecture. Atherosclerosis: a problem of the biology of arterial wall cells and their interactions with blood components. Arteriosclerosis (1982) 1.90
Serial magnetic resonance imaging of experimental atherosclerosis detects lesion fine structure, progression and complications in vivo. Nat Med (1995) 1.90
Glycoprotein encoded by the Friend spleen focus-forming virus. J Virol (1979) 1.89
Studies of hypercholesterolemia in the nonhuman primate. II. Fatty streak conversion to fibrous plaque. Arteriosclerosis (1984) 1.88
Cleavage of beta-catenin and plakoglobin and shedding of VE-cadherin during endothelial apoptosis: evidence for a role for caspases and metalloproteinases. Mol Biol Cell (1998) 1.87
Fatal metabolic acidosis in a pediatric patient receiving an infusion of propofol in the intensive care unit: is there a relationship? Crit Care Med (1995) 1.86
Physiological quiescence in plasma-derived serum: influence of platelet-derived growth factor on cell growth in culture. J Cell Physiol (1978) 1.85
One-year results of the Thrombolysis in Myocardial Infarction investigation (TIMI) Phase II Trial. Circulation (1992) 1.82
Comparison of the infusion requirements and recovery profiles of vecuronium and cisatracurium 51W89 in intensive care unit patients. Anesth Analg (1995) 1.80
Platelet-derived growth factor. III. Identification of a platelet-derived growth factor receptor by affinity labeling. J Biol Chem (1982) 1.79
Ganglioside-mediated modulation of cell growth, growth factor binding, and receptor phosphorylation. J Biol Chem (1984) 1.79
The elastic fiber. J Histochem Cytochem (1973) 1.79
Comparison of clinical outcomes for women and men after acute myocardial infarction. The Thrombolysis in Myocardial Infarction Investigators. Ann Intern Med (1994) 1.78
Wound healing and collagen formation. VI. The origin of the wound fibroblast studied in parabiosis. J Cell Biol (1970) 1.77
Nucleotide sequence of the gene coding for human factor VII, a vitamin K-dependent protein participating in blood coagulation. Proc Natl Acad Sci U S A (1987) 1.71
Degraded collagen fragments promote rapid disassembly of smooth muscle focal adhesions that correlates with cleavage of pp125(FAK), paxillin, and talin. J Cell Biol (1999) 1.70